CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 20 filers reported holding CLEVELAND BIOLABS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $0 | – | 31 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 31 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 31 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 31 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 31 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 31 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 31 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 31 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 31 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 31 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 31 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 31 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 31 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 31 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 31 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 31 | -55.1% | 0.00% | – |
Q1 2016 | $0 | – | 69 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 69 | +122.6% | 0.00% | – |
Q3 2015 | $0 | – | 31 | 0.0% | 0.00% | – |
Q2 2015 | $0 | – | 31 | 0.0% | 0.00% | – |
Q1 2015 | $0 | – | 31 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
THOMPSON DAVIS & CO., INC. | 1,800 | $8,000 | 0.01% |
VANGUARD GROUP INC | 4,644,077 | $162,991,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 38,888 | $158,000 | 0.00% |
Winfield Associates, Inc. | 786 | $3,000 | 0.00% |
Virtu KCG Holdings LLC | 11,022 | $48,000 | 0.00% |
UBS Group AG | 182 | $0 | 0.00% |
BLACKROCK ADVISORS LLC | 2,800 | $12,000 | 0.00% |
US BANCORP \DE\ | 100 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 37 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 150 | $1,000 | 0.00% |